CAS 845895-51-4

Formule : C26H30N5O2P

InChI : InChI=1S/C26H30N5O2P/c1-34(2,33)22-12-10-20(11-13-22)28-25-23-26(30-24(29-25)19-7-3-4-8-19)31(17-27-23)15-14-18-6-5-9-21(32)16-18/h5-6,9-13,16-17,19,32H,3-4,7-8,14-15H2,1-2H3,(H,28,29,30)

Code InChI : VVOYROSONSLQQK-UHFFFAOYSA-N

SMILES : CP(=O)(C)C1=CC=C(C=C1)NC2=C3C(=NC(=N2)C4CCCC4)N(C=N3)CCC5=CC(=CC=C5)O

AP23464

CAS : 845895-51-4

AP23464

Formule : C₂₆H₃₀N₅O₂P

Degré de pureté : 99.5%

Masse moléculaire : 475.52

Ref: 54-OR1142035

(4-((2-Cyclopentyl-9-(3-hydroxyphenethyl)-9H-purin-6-yl)amino)phenyl)dimethylphosphine oxide

CAS : 845895-51-4

Formule : C₂₆H₃₀N₅O₂P

Degré de pureté : 99%

Masse moléculaire : 475.52

Ref: IN-DG01416950

AP23464

CAS : 845895-51-4

AP23464 serves as a functional therapeutic tool specifically designed to enable the precise detection and inhibition of the oncogenic Kit and Bcr-Abl proteins which play pivotal roles in the maintenance of malignant cell survival and proliferation during strictly monitored laboratory observation periods and molecular investigations to evaluate the pharmacological efficacy of targeted kinase antagonism in specialized preclinical research environments to facilitate the development of novel cancer treatments.

Formule : C₂₆H₃₀N₅O₂P

Degré de pureté : 99.79%

Couleur et forme : White Solid

Masse moléculaire : 475.52

Ref: TM-T68581